Boston Interactome LLC
Publicly observedAllston, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Allston | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Boston Interactome LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | JH42ZH46EMF8 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2026Publicly observed
NIH SBIR/STTR award: Developing I2H for near-complete PPI-mapping and drug discovery
USD 349,753.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2025Publicly observed
NIH SBIR/STTR award: Developing high-precision epigenetic therapeutics for opioid use disorder
USD 119,942.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2025Publicly observed
NIH SBIR/STTR award: Developing high-precision epigenetic therapeutics for opioid use disorder
USD 278,195.00 · National Institute on Drug Abuse · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.